Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

12 results
  1. NLM Digital Collections - Controversies in migraine management : a technology assessment : final report 
    Publication: [Boston, MA] : Institute for Clinical and Economic Review, August 19, 2014
    ... frequency Model Results Findings for the comparison of BOTOX to placebo ... are also presented for reference. At a headache frequency of 20 days a ...
  2. NLM Digital Collections - Calcitonin gene-related peptide (CGRP) inhibitors as preventive treatments for patients with .... 
    Publication: [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 3, 2018
    ... chronic migraine may also use onabotulinum toxin A (Botox®, Allergan plc) injections for prevention.17 Patients on ... treatment with CGRP inhibitors and onabotulinum toxin A (Botox®, Allergan)? Yes: 0 votes No: 13 votes 4) ...
  3. NLM Digital Collections - Pharmacological management of migraine : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), February 2018
    ... and skin tightness.46,66 Botulinum toxin A (Botox®) has been accepted with restricted use in NHSScotland ... org.uk/emc/ medicine/6768 Botulinum toxin A (Botox®) is accepted for restricted use for the prophylaxis ...
  4. NLM Digital Collections - Management of patients with stroke : rehabilitation, prevention and management of ... 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), June 2010
    ... of recommendations Consider Clostridium botulinum toxin type A (Botox®) Not recommended routine resting splinting of the upper ... Clostridium botulinum toxin type A (both Dysport® and Botox®) reduce spasticity (measured by the Modified Ashworth Scale ...
  5. NLM Digital Collections - Medicare Part B : Medicare represented at least half of the market for 22 of the 84 most ... 
    Publication: Washington, DC : United States Government Accountability Office, December 2017
    ... 17 27 96 104 260,288 7 J0585 Botox (Onabotulinumtoxina injection) 15 256 21 116,587 2,195 ... Synthetic Brand only Single (Velaglucerase alfa) source J0585 Botox 15 1993 Musculoskeletal Biologic Brand only Single (Onabotulinumtoxina ...
  6. NLM Digital Collections - Medicaid today : preparing for tomorrow : a look at state Medicaid program spending, ... 
    Publication: Washington, DC : Henry J. Kaiser Family Foundation, October 2012
    ... All (+): Add coverage of new indications for Onabotulinum (Botox). Utah Vermont Virginia Washington Children (+): Add coverage of ... to add coverage of new indications for Onabotulinum (Botox) in early 2013.  Plan to add coverage of ...
  7. ... Food and Drug Administration (FDA). In contrast to Botox, which reduces furrowing of the brow by temporarily ...
  8. ... be post paid, and ad- dressed as follows: Botox: 1 FOWLER A!VD WELLS, j Philadelphia ; 142 ...
  9. NLM Digital Collections - The use of Oregon's evidence-based reviews for Medicaid pharmacy policies : experiences in ... 
    Publication: Washington, D.C. : Kaiser Commission on Medicaid and the Uninsured, May 2005
    ... Procrit/Epogen, Neupogen, OxyContin, Provigil, Celebrex, Bextra, Enbrel, Botox, Myobloc, and growth hormones. One state official explained ... Part D benefit in 2006 will begin to reference information in the DERP reports when designing their ...
  10. NLM Digital Collections - Management of hepatitis C : a national clinical guideline 
    Publication: Edinburgh, Scotland : Scottish Intercollegiate Guidelines Network (SIGN), July 2013
    ... yy piercing, tattooing and cosmetic injection procedures (eg botox) if any equipment is reused; yy sexual activity, ... term interferon treatment. | 49 Management of hepatitis C References 16. Henderson D. Managing occupational risks for hepatitis ...
previous · 1 · 2 · next